BlackRock Fund Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

BlackRock Fund Advisors’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$103K	Buy	105 +4	+4%	+$4.57K	﹤0.01%	3604
2016 Q3	$135K	Sell	101 -1	-1%	-$1.13K	﹤0.01%	3562
2016 Q2	$89K	Buy	102 +50	+96%	+$66.3K	﹤0.01%	3702
2016 Q1	$72K	Sell	52 -4	-7%	-$5.69K	﹤0.01%	3734
2015 Q4	$103K	Buy	+56	New	+$112K	﹤0.01%	3722

Other funds holding TCON

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock Fund Advisors's TCON Position: Q4 2016 in Review

BlackRock Fund Advisors increased its TRACON Pharmaceuticals, Inc. Common Stock (TCON) stake by 4% in Q4 2016, buying an estimated $4.57K and bringing the position to 105 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #3604.

BlackRock Fund Advisors first reported a position in TCON in Q4 2015 and has held it in 5 quarters since. The position peaked at $135K in Q3 2016. 31 funds tracked by Wall St. Rank hold TCON as of Q4 2016.

BlackRock Fund Advisors held 105 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $103K as of Q4 2016.
BlackRock Fund Advisors bought 4 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2016, an estimated $4.57K.
TRACON Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3604 holding.
BlackRock Fund Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $135K in Q3 2016.
31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.